Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Owlet Announces Fourth Quarter and Full Year 2024 Results

In This Article:

LEHI, Utah, March 04, 2025--(BUSINESS WIRE)--Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2024. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman, President and Chief Revenue Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, March 4, 2025, at 4:30 p.m. ET.

Q4 2024 Financial Highlights

  • Q4 Revenue of $20.5 million, compared to $21.0 million in Q4 2023. Excluding the revenue impact from the prior year Amazon distribution partner transition, which shifted $6 million of revenue from Q3 to Q4 2023, revenue was up 37% compared to Q4 2023

  • Q4 Gross Margin of 53.5%, up 650 basis points from Q4 2023

  • Q4 Net Loss of $(9.1) million, compared to $(6.9) million in Q4 2023

  • Q4 Adjusted EBITDA of $0.5 million, improving $1.2 million compared to Q4 2023

Full Year 2024 Financial Highlights

  • FY 2024 Revenue of $78.1 million, up 45% from 2023

  • FY 2024 Gross Margin of 50.4%, up 850 basis points from 2023

  • FY 2024 Net Loss of $(12.5) million, compared to $(32.9) million in 2023

  • FY 2024 Adjusted EBITDA of $(2.0) million, improving $14.3 million compared to 2023

"2024 was a pivotal year for Owlet, marking our strongest financial performance in company history," said Kurt Workman, Owlet’s Chief Executive Officer and Co-Founder. "We finished the year strong with fourth quarter results that exceeded our guidance across all key metrics. We made significant progress in the year, including launching the first and only FDA-cleared baby monitoring device, expanding internationally, and capturing market share, positioning Owlet as a clear leader in connected pediatric health."

Workman continued, "We continued our momentum entering 2025, launching Owlet360, our new subscription service leveraging Owlet’s massive pediatric health and sleep data set to deliver personalized, actionable insights to parents. Owlet360 represents a major step in our evolution into a comprehensive pediatric health platform, empowering families with the tools to bridge the gap between hospital and home care."

Workman concluded, "Looking ahead, we remain focused on scaling our core business, positioning for the large medical reimbursement opportunity, and accelerating growth in the Owlet360 subscription business. With a differentiated product portfolio, growing adoption, and a clear vision for the future, we believe Owlet is well-positioned to drive long-term, profitable growth while making a significant impact on pediatric health worldwide. I couldn’t be prouder of our team’s achievements, and I’m excited for what’s ahead."